107 related articles for article (PubMed ID: 1292471)
1. Interleukin-11 and its receptor.
Yang YC; Yin T
Biofactors; 1992 Dec; 4(1):15-21. PubMed ID: 1292471
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 11: an overview.
Yang YC
Stem Cells; 1993 Nov; 11(6):474-86. PubMed ID: 8111307
[TBL] [Abstract][Full Text] [Related]
3. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
4. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
5. Involvement of gp130/interleukin-6 receptor transducing component in interleukin-11 receptor.
Fourcin M; Chevalier S; Lebrun JJ; Kelly P; Pouplard A; Wijdenes J; Gascan H
Eur J Immunol; 1994 Jan; 24(1):277-80. PubMed ID: 8020567
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily.
Hirano T; Matsuda T; Nakajima K
Stem Cells; 1994 May; 12(3):262-77. PubMed ID: 8075593
[TBL] [Abstract][Full Text] [Related]
7. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
[TBL] [Abstract][Full Text] [Related]
8. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction.
Yin T; Taga T; Tsang ML; Yasukawa K; Kishimoto T; Yang YC
J Immunol; 1993 Sep; 151(5):2555-61. PubMed ID: 8360477
[TBL] [Abstract][Full Text] [Related]
9. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
[TBL] [Abstract][Full Text] [Related]
10. Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 protein.
Gimble JM; Wanker F; Wang CS; Bass H; Wu X; Kelly K; Yancopoulos GD; Hill MR
J Cell Biochem; 1994 Jan; 54(1):122-33. PubMed ID: 8126083
[TBL] [Abstract][Full Text] [Related]
11. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
[TBL] [Abstract][Full Text] [Related]
12. The biology of interleukin 11.
Neben S; Turner K
Stem Cells; 1993 Jul; 11 Suppl 2():156-62. PubMed ID: 8401258
[TBL] [Abstract][Full Text] [Related]
13. Hematopathology of interleukin 6-type cytokines.
Hawley RG
Stem Cells; 1994; 12 Suppl 1():155-71. PubMed ID: 7696960
[TBL] [Abstract][Full Text] [Related]
14. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 and related cytokines: effect on the acute phase reaction.
Heinrich PC; Horn F; Graeve L; Dittrich E; Kerr I; Müller-Newen G; Grötzinger J; Wollmer A
Z Ernahrungswiss; 1998; 37 Suppl 1():43-9. PubMed ID: 9558728
[TBL] [Abstract][Full Text] [Related]
16. [The interleukin-6 signal transducer, gp130, functioning in immune, hematopoietic, and neural systems].
Taga T
Nihon Rinsho; 1992 Aug; 50(8):1802-10. PubMed ID: 1433971
[TBL] [Abstract][Full Text] [Related]
17. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
[TBL] [Abstract][Full Text] [Related]
18. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
Westendorf JJ; Jelinek DF
J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
[TBL] [Abstract][Full Text] [Related]
19. Role of the interleukin 5 receptor system in hematopoiesis: molecular basis for overlapping function of cytokines.
Tominaga A; Takaki S; Hitoshi Y; Takatsu K
Bioessays; 1992 Aug; 14(8):527-33. PubMed ID: 1365906
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-11.
Kobayashi S; Teramura M; Oshimi K; Mizoguchi H
Leuk Lymphoma; 1994 Sep; 15(1-2):45-9. PubMed ID: 7532057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]